Fintech

Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials

Prnewswire·March 26, 2026 at 11:30 AM

/PRNewswire/ -- Pinnacle Medicines ("Pinnacle" or "the Company"), a biotechnology company pioneering the development of oral peptide therapeutics using...

Original Source

Prnewswire — www.prnewswire.com

Related in Fintech

Wells Fargo virtual assistant aids over 1 billion transactions
PYMNTS
White House crypto czar joins science advisory committee
CoinDesk
David Sacks leaves crypto post for White House
The Block
Lawmakers Question Bank Regulators on Fintech Rules
PYMNTS

Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials

Wells Fargo virtual assistant aids over 1 billion transactions

White House crypto czar joins science advisory committee

David Sacks leaves crypto post for White House

Lawmakers Question Bank Regulators on Fintech Rules